Compare Marvell Technology Inc (MRVL) vs Novavax Inc (NVAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Marvell Technology Inc vs Novavax Inc — how do they compare? Marvell Technology Inc trades at $211.72 (market cap $171.11B), while Novavax Inc trades at $8.06 (market cap $1.30B). The key difference: Marvell Technology Inc is far larger — about 131.6× Novavax Inc's market cap, and Marvell Technology Inc pays a 0.12% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| MRVL | NVAX | |
|---|---|---|
Market Cap | $171.11B | $1.30B |
Sector | Technology | Health |
52-Week High | $316.43 | $11.19 |
52-Week Low | $62.31 | $6.22 |
Enterprise Value | $172.55B | $800.50M |
Dividend Yield | 0.12% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Marvell Technology Inc
Marvell Technology is a leading fabless chipmaker focused on networking and storage applications. Marvell serves the data center, carrier, enterprise, automotive, and consumer end markets with processors, optical interconnections, application-specific integrated circuits (ASICs), and merchant silicon for Ethernet applications. The firm is an active acquirer, with five large acquisitions since 2017 helping it pivot out of legacy consumer applications to focus on the cloud and 5G markets.
Read more on MRVL →About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →
